June 18, 2020
JPMA President Joji Nakayama Joji Nakayama, president of the Japan Pharmaceutical Manufacturers Association (JPMA), on June 17 reiterated the group’s position that it is not the right time to conduct a drug price survey for “off-year” re-pricing next April as...read more